President Donald Trump said Saturday that he would decide next week whether the United States would abide by the 2015 Paris agreement on cutting global carbon emissions.
The unexpected announcement came as a summit of G7 leaders in Sicily wrapped up in deadlock on the issue, with US partners voicing frustration at the president's failure to commit to the deal aimed at stemming global warming.
‘I will make my final decision on the Paris Accord next week!’ Trump tweeted.
The US leader, concluding his first overseas trip in office, was due to fly home later Saturday without giving the customary close-of-summit press conference.
The meeting's final declaration reflected a stalemate between the US and the six other participating countries, who are all strongly committed to the Paris accord.
‘The United States of America is in the process of reviewing its policies on climate change and on the Paris Agreement and thus is not in a position to join the consensus on these topics,’ it stated.
‘Understanding this process, the (other participants) reaffirm their strong commitment to swiftly implement the Paris Agreement...
‘In this context, we all agree on the importance of supporting developing countries.’
German Chancellor Angela Merkel criticised what she called ‘a very difficult, not to say very unsatisfactory’ discussion with Trump on the issue.
‘Here we have a situation of six against one, meaning there is still no sign of whether the US will remain in the Paris accord or not,’ she said.
Other delegates concurred that it was ‘six against one’ at the gathering of leading democracies spanning North America, Europe and Japan.
Under Trump, who once called climate change a ‘hoax’ perpetrated by China, Washington has resisted intense pressure from its partners to commit to respecting the global 2015 accord on curbing carbon emissions.
But Gary Cohn, Trump's economic advisor, on Friday said the president had told his G7 colleagues that he regarded the environment as important.
‘His views are evolving, he came here to learn,’ Cohn said. ‘His basis for decision ultimately will be what's best for the United States.’
The United States is the world's biggest carbon emitter after China.
Trump had said he would listen to what US partners have to say at the G7 before making a decision on how to proceed.
- 'Make the right decision' -
Abandoning the Paris agreement would carry a high political cost internationally, with Europe, Canada, China and Japan all strongly committed to the deal.
It would also be fiercely opposed at home by environmental activists and by American corporations that are investing heavily in cleaner technology.
Greenpeace regretted the outcome but held out hope that Trump might change tack.
‘Europe, Canada and Japan stood up today and made a stand, revealing again how far Trump is out of step with the rest of the world on climate change,’ Jennifer Morgan, Greenpeace's international executive director, said in Sicily.
Nevertheless, the clean energy revolution is ‘unstoppable’ with support from other governments and from industry, she said.
‘Leaders must now keep resolve... President Trump should now return to Washington and make the right decision, take climate change seriously and take action with the rest of the world.’
Iain Keith, campaign director of Avaaz, an activist network, said: ‘Today, G6 leaders put our planet first, showing that even the US president cannot stop the inevitable clean energy revolution.’
‘Trump's attempts to derail global climate action won't make America great, it will only make America late.’
LEAVE A COMMENT Your email address will not be published. Required fields are marked*
Blanchett sees pandemic as chance for reflection on plight of refugees
Cheers, quiet reflection from American crowds marking Juneteenth
Bidens mourn the passing of ‘first dog’
'Apocalyptic' heat wave scorches US Southwest again
US sees ‘summer of joy’ as Covid shots surpass 300mn
Largest Boeing 737 Max model set for maiden flight
US suspects 4,000 cases of fraud in Iraqi refugee program: documents
US Supreme Court rejects challenge to Obamacare
First patient set to receive controversial Biogen Alzheimer's drug